For people switching from research-peptide sites

Your peptide source shut down. Switch to a licensed pharmacy.

Real prescriptions from a state-licensed U.S. pharmacy, named on your label. A licensed provider reviews your request, and you're not charged unless they approve.

  • Pharmacy named on every label
  • Licensed provider in your state
  • Not charged unless approved

Research site vs. Surna

FeatureSurnaResearch sites
Made by a state-licensed pharmacy✓–
Pharmacy named on your label✓–
Reviewed by a licensed provider✓–
Dosing guidance and follow-up✓–
Legal to prescribe and ship✓–

Available now with a prescription

Looking for something else? See all treatments or compare pricing.

Add what you're interested in to your request. A licensed provider reviews everything together and may prescribe none, some, or all. You're not charged unless a provider approves.

Peptide status tracker

Straight answers on what a licensed pharmacy can and can't provide right now. Last updated September 16, 2026.

PeptideWhere it standsAt Surna
BPC-157Recommended by an FDA advisory panel in July 2026. Awaiting FDA rulemaking.Not available yet
TB-500Recommended by an FDA advisory panel in July 2026. Awaiting FDA rulemaking.Not available yet
KPVRecommended by an FDA advisory panel in July 2026. Awaiting FDA rulemaking.Not available yet
MOTS-cRecommended by an FDA advisory panel in July 2026. Awaiting FDA rulemaking.Not available yet
SemaxRecommended by an FDA advisory panel in July 2026. Awaiting FDA rulemaking.Not available yet
EpitalonRecommended by an FDA advisory panel in July 2026. Awaiting FDA rulemaking.Not available yet
DSIP (emideltide)Not recommended by the FDA advisory panel in July 2026.Not available
CJC-1295Removed from the FDA restricted list in April 2026, but not cleared for compounding.Not available yet
GHK-Cu (injectable)Under FDA review, expected by early 2027.Not available yet
RetatrutideAn investigational drug still in clinical trials. It cannot be legally compounded.Not available

Start with what's available today

A licensed provider can review your health history and what you've been taking, and recommend a legal option from a licensed pharmacy. You're not charged unless a provider approves.

Switching questions

I've been using research peptides. Can I still get treated?

Yes. If you're switching from a research site, tell your provider what you've been taking. Your provider's job is to find a safe, legal option for you, not to judge how you got here.

Do I need to tell my provider what I've been taking?

Yes, please. Include what you took, how much, and when you last used it. It helps your provider choose a safe starting dose and avoid interactions.

Why can't you prescribe BPC-157 or TB-500?

They aren't legally available through licensed pharmacies yet. An FDA advisory panel recommended several peptides in July 2026, but the FDA still has to finish its rulemaking. Check the status tracker above for updates.

Why does it cost more than a research site?

You're paying for a licensed pharmacy that's named on your label, a provider who reviews your health history, and follow-up care when you need a dose change.

Is my information private?

Yes. Your health information is protected, and orders ship in discreet packaging.

When am I charged?

Only if a provider approves your request. If nothing is prescribed, you aren't charged.

Switch to a source you can trust.

Pick what you're interested in, and a licensed provider will review your request.

See what's available

Important safety information

GLP-1 medications may cause thyroid C-cell tumors, including medullary thyroid carcinoma, based on studies in rodents; it is unknown whether this happens in people. Do not use if you or a family member has had medullary thyroid carcinoma or if you have MEN 2. Other serious risks include pancreatitis, gallbladder problems, low blood sugar when used with other diabetes medicines, kidney problems from dehydration, serious allergic reactions, increased heart rate, and changes in vision for people with diabetic retinopathy. Watch for changes in mood or thoughts of self-harm and tell your provider right away.

This is not a complete list of risks. Talk with your provider and read the full prescribing information or medication guide. Full safety information.

See what's available